vs

Side-by-side financial comparison of Gauzy Ltd. (GAUZ) and Verastem, Inc. (VSTM). Click either name above to swap in a different company.

Gauzy Ltd. is the larger business by last-quarter revenue ($20.1M vs $11.2M, roughly 1.8× Verastem, Inc.). Gauzy Ltd. runs the higher net margin — -53.5% vs -876.3%, a 822.8% gap on every dollar of revenue.

Gauzy Ltd. is a technology firm specializing in advanced liquid crystal-based smart glass solutions. Its product portfolio includes switchable light control films, adaptive glass, and integrated sensing systems, serving core markets of automotive manufacturing, construction, and consumer electronics globally.

Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.

GAUZ vs VSTM — Head-to-Head

Bigger by revenue
GAUZ
GAUZ
1.8× larger
GAUZ
$20.1M
$11.2M
VSTM
Higher net margin
GAUZ
GAUZ
822.8% more per $
GAUZ
-53.5%
-876.3%
VSTM

Income Statement — Q2 FY2025 vs Q3 FY2025

Metric
GAUZ
GAUZ
VSTM
VSTM
Revenue
$20.1M
$11.2M
Net Profit
$-10.7M
$-98.5M
Gross Margin
21.4%
Operating Margin
-62.4%
-362.2%
Net Margin
-53.5%
-876.3%
Revenue YoY
-17.8%
Net Profit YoY
53.5%
-311.1%
EPS (diluted)
$-0.57
$-1.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GAUZ
GAUZ
VSTM
VSTM
Q3 25
$11.2M
Q2 25
$20.1M
$2.1M
Q3 24
$0
Q2 24
$24.4M
$10.0M
Net Profit
GAUZ
GAUZ
VSTM
VSTM
Q3 25
$-98.5M
Q2 25
$-10.7M
$-25.9M
Q3 24
$-24.0M
Q2 24
$-23.1M
$-8.3M
Gross Margin
GAUZ
GAUZ
VSTM
VSTM
Q3 25
Q2 25
21.4%
Q3 24
Q2 24
27.0%
Operating Margin
GAUZ
GAUZ
VSTM
VSTM
Q3 25
-362.2%
Q2 25
-62.4%
-2047.9%
Q3 24
Q2 24
-32.5%
-182.8%
Net Margin
GAUZ
GAUZ
VSTM
VSTM
Q3 25
-876.3%
Q2 25
-53.5%
-1213.6%
Q3 24
Q2 24
-94.6%
-82.6%
EPS (diluted)
GAUZ
GAUZ
VSTM
VSTM
Q3 25
$-1.35
Q2 25
$-0.57
$-0.62
Q3 24
$-0.60
Q2 24
$-2.60
$-0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GAUZ
GAUZ
VSTM
VSTM
Cash + ST InvestmentsLiquidity on hand
$1.2M
$137.7M
Total DebtLower is stronger
$44.0M
Stockholders' EquityBook value
$17.9M
$-15.5M
Total Assets
$136.8M
$176.9M
Debt / EquityLower = less leverage
2.46×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GAUZ
GAUZ
VSTM
VSTM
Q3 25
$137.7M
Q2 25
$1.2M
$164.3M
Q3 24
$113.2M
Q2 24
$63.7M
$83.4M
Total Debt
GAUZ
GAUZ
VSTM
VSTM
Q3 25
Q2 25
$44.0M
Q3 24
$40.5M
Q2 24
$35.4M
$40.3M
Stockholders' Equity
GAUZ
GAUZ
VSTM
VSTM
Q3 25
$-15.5M
Q2 25
$17.9M
$36.1M
Q3 24
$11.1M
Q2 24
$63.4M
$18.9M
Total Assets
GAUZ
GAUZ
VSTM
VSTM
Q3 25
$176.9M
Q2 25
$136.8M
$196.3M
Q3 24
$126.4M
Q2 24
$193.1M
$105.7M
Debt / Equity
GAUZ
GAUZ
VSTM
VSTM
Q3 25
Q2 25
2.46×
Q3 24
3.66×
Q2 24
0.56×
2.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GAUZ
GAUZ
VSTM
VSTM
Operating Cash FlowLast quarter
$-3.9M
$-36.2M
Free Cash FlowOCF − Capex
$-7.5M
FCF MarginFCF / Revenue
-37.5%
Capex IntensityCapex / Revenue
18.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GAUZ
GAUZ
VSTM
VSTM
Q3 25
$-36.2M
Q2 25
$-3.9M
$-32.7M
Q3 24
$-23.8M
Q2 24
$-15.7M
$-27.6M
Free Cash Flow
GAUZ
GAUZ
VSTM
VSTM
Q3 25
Q2 25
$-7.5M
Q3 24
Q2 24
$-20.0M
$-27.6M
FCF Margin
GAUZ
GAUZ
VSTM
VSTM
Q3 25
Q2 25
-37.5%
Q3 24
Q2 24
-82.0%
-275.8%
Capex Intensity
GAUZ
GAUZ
VSTM
VSTM
Q3 25
Q2 25
18.2%
Q3 24
Q2 24
17.8%
0.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons